人工膵臓市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）、2024最新版

Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日: 2024年09月17日
発行: GlobalData
ページ情報: 英文 115 Pages
納期: 即納可能

カスタマイズ可能

適宜更新あり

価格

PDF (Single User License)

USD 4,000 587,960円

レポートPDFを購入者の1名のみがご利用頂けるライセンスです。PDF内のテキストのコピーは可能です。PDFの印刷は可能ですが、印刷したもののご利用はPDFのご購入者のみに限定されます。

PDF (Site License)

USD 8,000 1,175,920円

レポートPDFについて、ご購入者が所属される同一事業所内の方で共有使用頂けます。同一事業所内であればご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDF内コンテンツの印刷は制限なく何回でも可能ではありますが、全頁印刷版の作成利用は基本的には2部までとし、そのご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 12,000 1,763,880円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

人工膵臓は、健康な膵臓の代替内分泌機能を提供することで、主に1型糖尿病患者の血糖値の自動的かつ継続的なコントロールを支援します。

当レポートでは、人工膵臓市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

Artificial Pancreas - Pipeline Products by Stage of Development
Artificial Pancreas - Pipeline Products by Territory
Artificial Pancreas - Pipeline Products by Regulatory Path
Artificial Pancreas - Pipeline Products by Estimated Approval Date
Artificial Pancreas - Ongoing Clinical Trials
Artificial Pancreas Companies - Pipeline Products by Stage of Development
Artificial Pancreas - Pipeline Products by Stage of Development
Glossary

List of Figures

Artificial Pancreas - Pipeline Products by Stage of Development
Artificial Pancreas - Pipeline Products by Territory
Artificial Pancreas - Pipeline Products by Regulatory Path
Artificial Pancreas - Pipeline Products by Estimated Approval Date
Artificial Pancreas - Ongoing Clinical Trials

Product Code: GDME1819EPD

GlobalData's Medical Devices sector report, "Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Artificial Pancreas under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Artificial Pancreas under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date